Systematic review and meta-analysis of Xu et al. showed that higher levels of glucose and fasting insulin, HOMA-IR, glycated hemoglobin (HbA1c) and peptide C were significantly associated with an increased risk of developing CRC. The gene discussed is INS; the disease is colorectal carcinoma.